Literature DB >> 16885201

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).

Valentin Fuster1, Lars E Rydén, David S Cannom, Harry J Crijns, Anne B Curtis, Kenneth A Ellenbogen, Jonathan L Halperin, Jean-Yves Le Heuzey, G Neal Kay, James E Lowe, S Bertil Olsson, Eric N Prystowsky, Juan Luis Tamargo, Samuel Wann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16885201     DOI： 10.1093/eurheartj/ehl176

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  110 in total

Review 1.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

2.  [Unclear hepatopathy in a patient with atrial fibrillation].

Authors:  C Pennartz; H Schrader; P R Ritter; A Tannapfel; W E Schmidt; J J Meier
Journal:  Internist (Berl)       Date:  2012-01       Impact factor: 0.743

Review 3.  [Cardiopulmonary emergencies during pregnancy and the postpartum period].

Authors:  M Rosenberg; N Frey
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-10       Impact factor: 0.840

Review 4.  [New oral anticoagulants: better than vitamin K antagonists?].

Authors:  H Völler; S Alban; D Westermann
Journal:  Internist (Berl)       Date:  2010-12       Impact factor: 0.743

5.  Towards a paradigm shift in atrial fibrillation.

Authors:  H J G M Crijns
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

6.  'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.

Authors:  W Dewilde; F W A Verheugt; N Breet; J J Koolen; J M Ten Berg
Journal:  Neth Heart J       Date:  2010-09       Impact factor: 2.380

Review 7.  Recent pharmacological advances for treating venous thromboembolism: are we witnessing the demise of warfarin?

Authors:  Shankar Kumar; John Howell; Christopher Mattock
Journal:  J R Soc Med       Date:  2013-09-11       Impact factor: 5.344

Review 8.  [New oral anticoagulants in atrial fibrillation].

Authors:  R Veltkamp; W Hacke
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

9.  [The patient with unclear palpitations: how extensive should the diagnostic approach be?].

Authors:  Thorsten Lewalter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-10-25

10.  Strategies for Risk Analysis and Disease Classification in Atrial Fibrillation.

Authors:  Sara Adelman; Georges Daoud; Peter J Mohler
Journal:  J Cardiovasc Electrophysiol       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.